Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 22.56
(-0.97%)
SAR 22.56
(-0.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 47 Million | -124.19 Million | 86.71 Million | 9.73 Million | 349.99 Million | -80.5 Million |
| Net Income | -9 Million | -146.24 Million | 31.55 Million | 155.1 Million | -449.39 Million | 102.82 Million |
| Depreciation & Amortization | 79 Million | 90.27 Million | 88.1 Million | 87.41 Million | 103.86 Million | 53 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -272 Million | 2.33 Million | 13.78 Million | -183.48 Million | 333.69 Million | -184.72 Million |
| Other non-cash items | 249 Million | -70.55 Million | -46.73 Million | -49.3 Million | 361.81 Million | -183.33 Million |
| Investing Cash Flow | -172 Million | 478.19 Million | 141.47 Million | -146.58 Million | -343.22 Million | -42.08 Million |
| Investments in PPE | -117.35 Million | -84.63 Million | -83.87 Million | -183.36 Million | -341.59 Million | -281.04 Million |
| Acquisitions | 4.36 Million | 4.35 Million | -2.41 Million | -2.12 Million | -36.9 Million | 15.46 Million |
| Investment purchases | -70.5 Million | -45 Million | -145.3 Million | -593.21 Million | -20 Million | -42.7 Million |
| Sales/Maturities of investments | -4.36 Million | 570.88 Million | 341.46 Million | 589.49 Million | 12.43 Million | 239.22 Million |
| Other Investing Activities | 15.85 Million | 32.59 Million | 31.61 Million | 42.62 Million | 42.83 Million | -42.08 Million |
| Financing Cash Flow | -32 Million | -310.85 Million | -240.95 Million | 78.85 Million | 104.9 Million | 33.63 Million |
| Debt repayment | -43.94 Million | -215.1 Million | -61.54 Million | -139.54 Million | -201.8 Million | -214.08 Million |
| Dividends payments | -461 Thousand | -70.73 Million | -118.11 Million | -58.97 Million | -118.12 Million | -176.02 Million |
| Common Stock Repurchased | -8 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 812 Thousand | -25.01 Million | -61.29 Million | 277.37 Million | 424.84 Million | 33.63 Million |
| Accounts receivables | -161.73 Million | 172.69 Million | 13.02 Million | -51.66 Million | 58.28 Million | 3.55 Million |
| Accounts payables | 103.53 Million | -57.95 Million | -14.26 Million | -105.85 Million | 157.6 Million | -103.75 Million |
| Inventory | -143.02 Million | 172.69 Million | 18.02 Million | -44.34 Million | 60.35 Million | -35.08 Million |
| Other working capital | -70.77 Million | -285.08 Million | -2.99 Million | 18.38 Million | 57.45 Million | -49.43 Million |
| Cash at beginning of period | 335.34 Million | 329.66 Million | 334.08 Million | 378.97 Million | 267.3 Million | 356.68 Million |
| Cash at end of period | 160 Million | 670.69 Million | 659.32 Million | 668.16 Million | 757.94 Million | 267.73 Million |
| Capital Expenditure | -117.35 Million | -84.63 Million | -83.87 Million | -183.36 Million | -341.59 Million | -281.04 Million |
| Effect of forex changes on cash | -16.14 Million | -37.46 Million | 8.34 Million | 13.1 Million | 378.97 Million | - |
| Net cash flow / Change in cash | -175.34 Million | 341.03 Million | 325.24 Million | 289.18 Million | 490.64 Million | -88.95 Million |
| Free Cash Flow | -70.35 Million | -208.83 Million | 2.83 Million | -173.62 Million | 8.39 Million | -361.54 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 29.8 Million | 39 Million | -9 Million | -49 Million | -34.02 Million | 25.1 Million |
| Depreciation & Amortization | 21.08 Million | 20 Million | 79 Million | 17 Million | 19.95 Million | 20.58 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -260.23 Million | -192 Million | -272 Million | 111.12 Million | 68.13 Million | -119.6 Million |
| Other non-cash items | 389.21 Million | 127 Million | 249 Million | 53.06 Million | 76.04 Million | 19.69 Million |
| Investing Cash Flow | 2.22 Million | -29 Million | -172 Million | -59.16 Million | -29.81 Million | -27.57 Million |
| Investments in PPE | -35.9 Million | -22.79 Million | -117.35 Million | -52.1 Million | -26.81 Million | -15.07 Million |
| Acquisitions | -26.87 Million | - | 4.36 Million | 6.65 Million | -5 Million | 2.72 Million |
| Investment purchases | 21.5 Million | -21.5 Million | -70.5 Million | -15 Million | -3 Million | -12.5 Million |
| Sales/Maturities of investments | 43.5 Million | - | -4.36 Million | -10.2 Million | 73.36 Million | 9.92 Million |
| Other Investing Activities | 27.1 Million | -6.19 Million | 15.85 Million | 11.49 Million | -68.35 Million | -12.64 Million |
| Financing Cash Flow | 217.44 Million | 136 Million | -32 Million | -47.84 Million | -130.84 Million | -29.99 Million |
| Debt repayment | -230.13 Million | -151.44 Million | -43.94 Million | -28.2 Million | -124.94 Million | -30.9 Million |
| Dividends payments | -576 Thousand | -207 Thousand | -461 Thousand | -125 Thousand | -266 Thousand | -70 Thousand |
| Common Stock Repurchased | -11.15 Million | - | -8 Million | -8 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 87 Thousand | 51 Thousand | 812 Thousand | -795 Thousand | -5.63 Million | 980.35 Thousand |
| Accounts receivables | -164.96 Million | -262.36 Million | -161.73 Million | 222.02 Million | 92.23 Million | -107.36 Million |
| Accounts payables | -144 Million | 78.82 Million | 103.53 Million | 10.69 Million | 9.7 Million | -36.02 Million |
| Inventory | 46.18 Million | 24.39 Million | -143.02 Million | -100.29 Million | -33.81 Million | 4.59 Million |
| Other working capital | 2.55 Million | -192 Million | -70.77 Million | -21.3 Million | -11.56 Million | 19.17 Million |
| Cash at beginning of period | 227.02 Million | 160.06 Million | 335.34 Million | 135.21 Million | 173.87 Million | 285.68 Million |
| Cash at end of period | 315.47 Million | 227 Million | 160 Million | 160 Million | 135.21 Million | 173.87 Million |
| Capital Expenditure | -35.9 Million | -22.79 Million | -117.35 Million | -52.1 Million | -26.81 Million | -15.07 Million |
| Effect of forex changes on cash | -6.49 Million | 5.95 Million | -16.14 Million | 1.8 Million | -8.1 Million | -13.46 Million |
| Net cash flow / Change in cash | 88.44 Million | 66.93 Million | -175.34 Million | 24.78 Million | -38.66 Million | -111.8 Million |
| Free Cash Flow | -160.98 Million | -68.79 Million | -70.35 Million | 80.08 Million | 103.28 Million | -69.3 Million |
002063
ATLN
GMVHF
CTOC
GET
VEON